SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-027699
Filing Date
2011-05-10
Accepted
2011-05-10 16:31:27
Documents
10
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v221327_10q.htm 10-Q 541767
2 CONTRACT, EFFECTIVE AS OF FEBRUARY 24, 2011, BETWEEN THE COMPANY AND HHS/OS/ASP v221327_ex10-1.htm EX-10.1 732309
3 GRAPHIC ex10-1pg1.jpg GRAPHIC 306562
4 LICENSE AGREEMENT, ENTERED IN FEBRUARY 25, 2011, EFFECTIVE AS OF DECEMBER 9, 20 v221327_ex10-2.htm EX-10.2 208196
5 GUIDELINES ON SIGNIFICANT CORPORATE GOVERNANCE ISSUES EFFECTIVE AS OF JANUARY 1 v221327_ex10-3.htm EX-10.3 46970
6 GRAPHIC logo.jpg GRAPHIC 18941
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) OR 15D-14(E v221327_ex31-1.htm EX-31.1 13600
8 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) OR 15D-14(E v221327_ex31-2.htm EX-31.2 11736
9 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS v221327_ex32-1.htm EX-32.1 5798
10 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS v221327_ex32-2.htm EX-32.2 5828
  Complete submission text file 0001144204-11-027699.txt   2015942
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 11828621
SIC: 2836 Biological Products, (No Diagnostic Substances)